Detalhe da pesquisa
1.
NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.
Br J Cancer
; 130(3): 476-482, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38135713
2.
A phase 1b expansion study of TAS-102 with oxaliplatin for refractory metastatic colorectal cancer.
Cancer
; 127(9): 1417-1424, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33351187
3.
Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer.
Br J Cancer
; 114(7): 737-43, 2016 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27022826
4.
Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and E.
Clin Colorectal Cancer
; 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38653648
5.
Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysis.
Clin Transl Radiat Oncol
; 27: 15-23, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33392398
6.
A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Borderline and Locally Advanced Unresectable Pancreatic Cancer.
Pancreas
; 49(7): 904-911, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32658074
7.
Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313.
J Clin Oncol
; 37(13): 1062-1069, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30817250
8.
Phase II Study of Modified FOLFOX6 With Bevacizumab in Metastatic Gastroesophageal Adenocarcinoma.
Am J Clin Oncol
; 40(2): 146-151, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25144267